Russell Investments Group Ltd. decreased its position in shares of Davita Inc (NYSE:DVA) by 67.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 54,862 shares of the company’s stock after selling 115,998 shares during the quarter. Russell Investments Group Ltd.’s holdings in Davita were worth $3,259,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Rhumbline Advisers increased its holdings in shares of Davita by 4.4% during the third quarter. Rhumbline Advisers now owns 321,155 shares of the company’s stock valued at $19,073,000 after acquiring an additional 13,471 shares in the last quarter. Riverhead Capital Management LLC boosted its position in shares of Davita by 10.6% during the second quarter. Riverhead Capital Management LLC now owns 112,506 shares of the company’s stock valued at $7,286,000 after buying an additional 10,775 shares during the last quarter. Founders Capital Management LLC boosted its position in shares of Davita by 2.3% during the third quarter. Founders Capital Management LLC now owns 95,939 shares of the company’s stock valued at $5,698,000 after buying an additional 2,115 shares during the last quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH boosted its position in shares of Davita by 1,987.3% during the third quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH now owns 41,746 shares of the company’s stock valued at $2,448,000 after buying an additional 39,746 shares during the last quarter. Finally, Speece Thorson Capital Group Inc. boosted its position in shares of Davita by 14.5% during the third quarter. Speece Thorson Capital Group Inc. now owns 321,182 shares of the company’s stock valued at $19,075,000 after buying an additional 40,667 shares during the last quarter. Hedge funds and other institutional investors own 85.32% of the company’s stock.

Several brokerages recently issued reports on DVA. Robert W. Baird raised Davita from a “neutral” rating to an “outperform” rating and lifted their target price for the company from $63.00 to $82.00 in a research report on Tuesday, December 12th. Citigroup raised Davita from a “neutral” rating to a “buy” rating and lifted their target price for the company from $67.71 to $82.00 in a research report on Monday, December 11th. J P Morgan Chase & Co lifted their target price on Davita from $4.90 to $84.00 and gave the company a “strong-buy” rating in a research report on Thursday, December 7th. SunTrust Banks set a $70.00 target price on Davita and gave the company a “hold” rating in a research report on Thursday, December 7th. Finally, Raymond James Financial raised Davita from an “outperform” rating to a “strong-buy” rating and lifted their target price for the company from $65.00 to $84.00 in a research report on Thursday, December 7th. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating, three have given a buy rating and two have issued a strong buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $73.33.

Davita Inc (NYSE DVA) opened at $70.52 on Monday. The company has a debt-to-equity ratio of 1.79, a current ratio of 1.40 and a quick ratio of 1.35. Davita Inc has a 1 year low of $52.51 and a 1 year high of $71.47. The firm has a market capitalization of $12,926.32, a price-to-earnings ratio of 20.15, a price-to-earnings-growth ratio of 14.23 and a beta of 0.97.

Davita (NYSE:DVA) last posted its quarterly earnings data on Tuesday, November 7th. The company reported $0.81 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.94 by ($0.13). Davita had a return on equity of 13.31% and a net margin of 3.40%. The business had revenue of $3.92 billion during the quarter, compared to analysts’ expectations of $3.91 billion. During the same period in the prior year, the firm posted $0.95 EPS. The firm’s revenue for the quarter was up 5.2% on a year-over-year basis. equities analysts expect that Davita Inc will post 3.42 EPS for the current year.

Davita announced that its Board of Directors has initiated a stock buyback plan on Tuesday, October 10th that permits the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization permits the company to purchase shares of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s board of directors believes its stock is undervalued.

In other Davita news, VP Leanne M. Zumwalt sold 949 shares of the business’s stock in a transaction on Friday, December 8th. The stock was sold at an average price of $68.19, for a total value of $64,712.31. Following the transaction, the vice president now owns 12,423 shares of the company’s stock, valued at $847,124.37. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Javier Rodriguez sold 22,532 shares of the business’s stock in a transaction on Thursday, December 7th. The stock was sold at an average price of $67.48, for a total value of $1,520,459.36. Following the completion of the transaction, the chief executive officer now directly owns 210,317 shares in the company, valued at approximately $14,192,191.16. The disclosure for this sale can be found here. In the last three months, insiders sold 117,937 shares of company stock worth $8,028,379. Insiders own 2.10% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Russell Investments Group Ltd. Sells 115,998 Shares of Davita Inc (DVA)” was posted by Watch List News and is the property of of Watch List News. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://www.watchlistnews.com/russell-investments-group-ltd-sells-115998-shares-of-davita-inc-dva/1770889.html.

Davita Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Institutional Ownership by Quarter for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.